SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 197 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,541,444 | +122.8% | 260,200 | +110.5% | 5.74% | +107.3% |
| Q2 2023 | $14,154,672 | +49.6% | 123,600 | +69.3% | 2.77% | +49.5% |
| Q4 2022 | $9,459,340 | -34.9% | 73,000 | -62.4% | 1.85% | -46.8% |
| Q2 2022 | $14,535,000 | +11.0% | 193,900 | +33.4% | 3.49% | +19.8% |
| Q4 2021 | $13,094,000 | +15.5% | 145,405 | -41.8% | 2.91% | +31.9% |
| Q3 2017 | $11,340,000 | +148.9% | 250,000 | +4.6% | 2.21% | +69.0% |
| Q2 2016 | $4,556,000 | +55.6% | 238,900 | +59.3% | 1.30% | +24.2% |
| Q1 2016 | $2,928,000 | – | 150,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |